OWC Pharmaceutical Research's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; OWC Pharmaceutical Research is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -587.00K	$ -715.00K	$ -783.00K	$ -7.64M	$ -669.00K
EBITDA	$ -585.00K	$ -711.00K	$ -781.00K	$ -7.64M	$ -667.00K
Net Income Common Stockholders	$ -1.05M	$ 6.89M	$ -2.06M	$ -6.08M	$ -1.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.47M	$ 1.84M	$ 2.80M	$ 3.46M	$ 4.22M
Total Assets	$ 1.77M	$ 2.33M	$ 2.95M	$ 3.55M	$ 4.31M
Total Debt	$ 47.00K	$ 53.00K	$ 60.00K	$ 0.00	$ 0.00
Net Debt	$ -1.42M	$ -1.79M	$ -2.74M	$ -3.46M	$ -4.22M
Total Liabilities	$ 5.78M	$ 5.38M	$ 13.19M	$ 12.99M	$ 8.10M
Stockholders Equity	$ -4.01M	$ -3.04M	$ -10.24M	$ -9.44M	$ -3.79M
Cash Flow	-
Free Cash Flow	$ -372.00K	$ -957.00K	$ -665.00K	$ -756.00K	$ -430.00K
Operating Cash Flow	$ -372.00K	$ -955.00K	$ -665.00K	$ -751.00K	$ -427.00K
Investing Cash Flow	$ 0.00	$ -2.00K	$ 0.00	$ -5.00K	$ -3.00K
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00

Currency in USD

OWC Pharmaceutical Research Earnings and Revenue History

Income Statement >

OWC Pharmaceutical Research Debt to Assets

Balance Sheet >

OWC Pharmaceutical Research Cash Flow

Cash Flow >

OWC Pharmaceutical Research Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing